| # | Drug | Count |
|---|---|---|
| 0 | FENTANYL | 10 |
| 1 | MIDAZOLAM HYDROCHLORIDE | 10 |
| 2 | MIDAZOLAM | 9 |
| 3 | CARBOPLATIN | 8 |
| 4 | PACLITAXEL | 7 |
| 5 | PACLITAXEL (AIBUMIN-BOUND) | 7 |
| 6 | PEMBROLIZUMAB | 7 |
| 7 | PROPOFOL | 7 |
| 8 | LACOSAMIDE | 5 |
| 9 | LEVETIRACETAM | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DESIPRAMINE HYDROCHLORIDE | 1 | 0.0036 |
| 1 | CORTISOL | 1 | 0.0025 |
| 2 | DIFLUNISAL | 1 | 0.0012 |
| 3 | DOBUTAMINE HYDROCHLORIDE | 1 | 0.0008 |
| 4 | NALDEMEDINE | 1 | 0.0006 |
| 5 | DEXMEDETOMIDINE | 2 | 0.0006 |
| 6 | BREXUCABTAGENE AUTOLEUCEL | 1 | 0.0005 |
| 7 | MIDAZOLAM HYDROCHLORIDE | 10 | 0.0004 |
| 8 | PATISIRAN | 1 | 0.0004 |
| 9 | DEXMEDETOMIDINE HYDROCHLORIDE | 1 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | beta Lactamase Inhibitor [EPC] | 1 | 0.0002 |
| 1 | General Anesthetic [EPC] | 7 | 0.0002 |
| 2 | Noncompetitive AMPA Glutamate Receptor Antagonist [EPC] | 1 | 0.0001 |
| 3 | CD19-directed Chimeric Antigen Receptor [EPC] | 1 | 0.0001 |
| 4 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 1 | 0.0001 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 7 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | Vasopressin V2 Receptor Antagonist [EPC] | 1 | 0.0001 |
| 9 | Microtubule Inhibitor [EPC] | 7 | 0.0000 |